Here, Liang explains his latest hepatocellular ... on inflammatory microenvironment modulation for improved response rate. Ultimately, we aim to reverse the progression of cancer both in terms ...

The tumor microenvironment (TME) consists of a complex mix of cellular and non-cellular components, including immune cells, ...

Hepatocellular carcinoma (HCC), the third leading cause ... revealed that tumor-derived HDAC2-AS2 is secreted into the tumor ...

Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...

HCC represents the third leading cause of cancer-related mortality globally ... and dynamic interplay within the tumor immune ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

DelveInsight's Hepatocellular Carcinoma pipeline report depicts a robust space with 90+ active players working to develop 95+ pipeline therapies for Hepatocellular Carcinoma treatment.

The downregulation of ADH4 expression induces hepatocyte apoptosis, thereby contributing to liver fibrosis and the initiation of hepatocellular ... homeostasis and cancer progression, emphasizing ...

Study demonstrates PLT012 reprograms tumor immunity by targeting metabolic suppression in hepatocellular carcinoma (HCC) and liver metastases Findings establish proof-of-concept for CD36 as a novel ...